Dalena Capital
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://dalena.vc
- HQ
- CA
Dalena Capital aims to build an ecosystem where science, early-stage capital, and operational discipline support founders creating life-changing medicines. The firm focuses on seed-stage companies that translate breakthrough science into novel medicines.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Seed | Not enough dated deals |
| Sectors | Biotech | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Dalena Capital Fund I, LP Dalena Capital backs seed-stage companies translating breakthrough science into novel medicines, combining world-class science, early-stage capital, and operational discipline to support founders building life-changing medicines. Inferred from the firm's website | 2025 | $2.55M to $5M (Form D) | Raising |
03 · People across funds
- Katherine Moortgat, Managing Partner of the Manager of the General Partner of the Fund
Dalena Capital Fund I, LP (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026